World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
14578
World Ranking
3309
National Ranking
1538

Jintanat Ananworanich publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jintanat Ananworanich sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 432 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jintanat Ananworanich D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jintanat Ananworanich sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jintanat Ananworanich is affiliated with Moderna Therapeutics in the United States. Their research focuses extensively on infectious diseases, particularly HIV/AIDS, contributing to the fields of Medicine and Immunology and Microbiology. The scientist has a substantial publication record covering diverse aspects of HIV research, immune cell function, and virology.

Their main topics of work include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Immune Cell Function and Interaction
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • T-cell and B-cell Immunology
  • Cytomegalovirus and herpesvirus research

Jintanat Ananworanich's frequent publication venues illustrate the primary forums for their scientific contributions:

  • Clinical Infectious Diseases
  • AIDS
  • Journal of Virus Eradication
  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • UNC Libraries

Frequent collaborators in their scientific output include Eugène Kroon, Nittaya Phanuphak, Carlo Sacdalan, Suteeraporn Pinyakorn, and Merlin L. Robb, highlighting a network of co-authors who have worked extensively together.

Selected recent papers authored or co-authored by Jintanat Ananworanich are:

  • "HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases" (2020, Nature Communications)
  • "Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection" (2020, Science Translational Medicine)
  • "Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies" (2021, Clinical Infectious Diseases)
  • "HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections" (2023, Immunity)
  • "Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption" (2020, Nature Medicine)

Their work spans subfields such as infectious diseases, virology, immunology, epidemiology, and emergency medicine, indicating a multidisciplinary approach within their primary research areas.

Best Publications

  • Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

    Victor Valcour;Thep Chalermchai;Napapon Sailasuta;Mary Marovich

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • Predictors of disease progression in HIV infection: a review

    Simone Elisabeth Langford;Jintanat Ananworanich;David A Cooper

  • Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection.

    Jintanat Ananworanich;Alexandra Schuetz;Claire Vandergeeten;Irini Sereti

  • Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.

    Donn J. Colby;Lydie Trautmann;Lydie Trautmann;Suteeraporn Pinyakorn;Suteeraporn Pinyakorn;Louise Leyre

  • Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.

    Irini Sereti;Shelly J. Krebs;Nittaya Phanuphak;James L. Fletcher

  • CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial

    Jintanat Ananworanich;Angèle Gayet-Ageron;Michelle Le Braz;Wisit Prasithsirikul

  • Cross-Clade Ultrasensitive PCR-Based Assays To Measure HIV Persistence in Large-Cohort Studies

    Claire Vandergeeten;Rémi Fromentin;Esther Merlini;Mariam B. Lawani

  • HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART

    Jintanat Ananworanich;Jintanat Ananworanich;Nicolas Chomont;Leigh Ann Eller;Leigh Ann Eller;Eugene Kroon

  • Initiation of ART during Early Acute HIV Infection Preserves Mucosal Th17 Function and Reverses HIV-Related Immune Activation

    Alexandra Schuetz;Claire Deleage;Irini Sereti;Rungsun Rerknimitr

  • Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1.

    Drew Weissman;Yuexia Li;Jintanat Ananworanich;Liang-Ji Zhou

  • HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.

    Alexandra Calmy;Angèle Gayet-Ageron;Fabrizio Montecucco;Alain Nguyen

  • HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases.

    I. Vujkovic-Cvijin;O. Sortino;E. Verheij;J. Sklar

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting

    Boris Julg;Boris Julg;Lynda Dee;Jintanat Ananworanich;Dan H Barouch;Dan H Barouch

  • Cognitive Function and Neurodevelopmental Outcomes in HIV-Infected Children Older than 1 Year of Age Randomized to Early Versus Deferred Antiretroviral Therapy: The PREDICT Neurodevelopmental Study

    Thanyawee Puthanakit;Jintanat Ananworanich;Saphonn Vonthanak;Pope Kosalaraksa

  • First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

    Linda Harrison;Abdel Babiker;Hannah Castro;Alexandra Compagnucci

  • Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation

    Irini Sereti;Shelly J. Krebs;Shelly J. Krebs;Nittaya Phanuphak;James L. Fletcher

  • Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection

    Napapon Sailasuta;William Ross;Jintanat Ananworanich;Thep Chalermchai

  • Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.

    Jintanat Ananworanich;Thanyawee Puthanakit;Piyarat Suntarattiwong;Kulkanya Chokephaibulkit

  • Clinical and public health implications of acute and early HIV detection and treatment: a scoping review

    Sarah E. Rutstein;Jintanat Ananworanich;Sarah Fidler;Cheryl Johnson

  • How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs

    Jintanat Ananworanich;Karine Dubé;Nicolas Chomont

Frequent Co-Authors

Kiat Ruxrungtham
Kiat Ruxrungtham Chulalongkorn University
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Serena Spudich
Serena Spudich Yale University
Jerome H. Kim
Jerome H. Kim Walter Reed Army Institute of Research
Nicolas Chomont
Nicolas Chomont University of Montreal
David A. Cooper
David A. Cooper University of New South Wales
David M. Burger
David M. Burger Radboud University
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Irini Sereti
Irini Sereti National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding your education into healthcare-related fields can open diverse career pathways. Those aiming for advanced nursing roles might explore specialized programs, such as accelerated pathways tailored for quicker entry into practice.

Non-nurses considering a shift into nursing can benefit greatly from online ABSN programs for non nurses. These programs provide an efficient route from a non-nursing background to becoming a Registered Nurse (RN).

Nurses focused on family care often choose to advance their skills by transitioning through an FNP to ACNP bridge program online. This pathway enables them to expand their expertise into acute care, making them more versatile in clinical settings.

Additionally, those looking to enter the nurse practitioner role quickly should consider accelerated FNP programs, which expedite preparation for certification and practice.

Understanding earning potentials is key for career planning. For example, knowing how much do DNP nurses make across different states helps prospective students make informed decisions about their studies and future employment.

Best Scientists Citing Jintanat Ananworanich

Trending Scientists

Recently Published Articles